Daniel Araujo, MD, who has joined the UF College of Medicine as an associate professor in the Division of Hematology & Oncology, strives to provide the best…| ufhealth.org
The program develops and translates immunotherapy modalities, such as RNA-based vaccines, adoptive cellular therapies, genetically modified T cells and microbiome-based therapy, into first-in-human studies. The Comparative Oncology Initiative has allowed IOM investigators to validate new technologies in pet dog trials while a cadre of clinical trialists move these and other UF findings into human application.…| Cancer Center
